Biotie Therapies (Biotie) has appointed Panu Miettinen as chief financial officer (CFO). He will become a member of the group’s management team and will report to Timo Veromaa, president and chief executive officer (CEO). Miettinen will be based at the company’s headquarters in Turku, Finland. Zack McNealy, current interim CFO, will resume his prior duties as vice president, finance and administration at the group’s US subsidiary.
Miettinen, a Finnish native, has expertise in finance, strategy, investor relations, and merger and acquisitions (M&A). Previously he was the CFO of Elektrobit. Before joining Elektrobit, Miettinen was a management consultant at Accenture and KPMG Consulting. Miettinen holds an MSc (Economics) degree from Helsinki School of Economics, Finland.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more